Results 81 to 90 of about 28,472 (205)

Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany

International Journal of Ophthalmology, 2013
AIM: To evaluate 5-year effectiveness and cost between latanoprost or timolol monotherapy in a pilot trial. METHODS: A retrospective, multi-center trial performed at 6 sites in Germany of patients who had a diagnosis of primary open-angle or ...
Jeanette A. Stewart, Lindsay A. Nelson, Michael S. Kristoffersen, Sonja Schölzel, Dietmar Schnober, Ulrich Thelen, William C. Stewart   +6 more
doaj   +1 more source

FORMULATION AND CHARACTERIZATION OF TIMOLOL MALEATE-LOADED NANOPARTICLES GEL BY IONIC GELATION METHOD USING CHITOSAN AND SODIUM ALGINATE

International Journal of Applied Pharmaceutics, 2019
Objective: The objectives of this study were to formulate and characterize nanoparticles gel of timolol maleate (TM) by ionic gelation method using chitosan (CS) and sodium alginate (SA).
Risa Ahdyani, Laras Novitasari, R. Martien   +2 more
semanticscholar   +1 more source

Quantification method for timolol from in vivo samples for the development of a new glaucoma drug depot

Current Directions in Biomedical Engineering, 2018
Glaucoma is the second most common cause of blindness. An increased intraocular pressure is the only treatable symptom of glaucoma. Because patients often exhibit a poor therapy adherence, a drug depot consisting of ELA-NCO and hyaluronic acid with ...
Eickner Thomas, Kopp Franziska, Brietzke Andreas, Kischkel Sabine, Oschatz Stefan, Schmitz Klaus-Peter, Guthoff Rudolf, Grabow Niels   +7 more
doaj   +1 more source

From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient

Case Reports in Critical Care, 2015
Timolol Maleate (also called Timolol) is a nonselective beta-adrenergic blocker and a class II antiarrhythmic drug, which is used to treat intraocular hypertension.
Muhammad Asim Rana, Ahmed Fouad Mady, Basheer Abdel Rehman, Abdulrahman Alharthy, Basim Huwait, Asim Riaz, Waleed Tharwat Aletreby   +6 more
doaj   +1 more source

Complete atrioventricular block due to timolol eye drops: a case report and literature review

BMC Pharmacology and Toxicology, 2019
Background Timolol Maleate is a non-selective beta-adrenergic blocker that is commonly used to treat open-angle glaucoma. Despite its topical administration, ophthalmic timolol enters systemic circulation and produces a systemic beta-adrenergic blockade.
Zhuoying Wang, Ian Denys, Feng Chen, Lijie Cai, Xuecui Wang, Daniel R. Kapusta, Yongliang Lv, Juan Gao   +7 more
doaj   +1 more source

Symptomatic Bradycardia and Syncope due to Ophthalmic Timolol Maleate

Çukurova Üniversitesi Tıp Fakültesi Dergisi, 2014
Timolol maleate is a non-selective (effective to and szlig;1 and and szlig;2 receptors) is a topical beta blocker drug which is used in the treatment of glaucoma. Besides its topical impact, it may have some systemic side effects.
Muge Gulen, Mehmet Oguzhan Ay, Davut Kaplan, Selen Acehan, Ferhat icme   +4 more
doaj  

Tolosa-Hunt syndrome after chikungunya infection [PDF]

Revista Brasileira de Oftalmologia
This case report aimed to describe the Tolosa-Hunt syndrome in a patient infected with chikungunya and highlight the relevance of considering chikungunya as a possible cause of the Tolosa-Hunt syndrome, especially in endemic or epidemic infection sites ...
Celso Busnelo Moreno, Jade Pinto de Queiroz Guerra, João Marcelo Cecílio Ribeiro, Guilherme Novoa Colombo-Barboza, Marcello Novoa Colombo-Barboza, Priscilla Fernandes Nogueira   +5 more
doaj   +1 more source

FACTORIAL DESIGN AS THE METHOD IN THE OPTIMIZATION OF TIMOLOL MALEATE-LOADED NANOPARTICLE PREPARED BY IONIC GELATION TECHNIQUE

International Journal of Applied Pharmaceutics, 2019
Objective: This study aims to optimize the timolol maleate (TM) nanoparticle prepared by ionic gelation method using the factors of pectin (PC), calcium chloride (CC), and chitosan (CS) concentrations with the responses of entrapment efficiency, particle
Wildan Khairi Muhtadi, Laras Novitasari, R. Martien, Retno Danarti   +3 more
semanticscholar   +1 more source

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy

Clinical Ophthalmology, 2012
Kenji Inoue,1 Takayuki Fujimoto,1 Risako Higa,1 Ryo Moriyama,1 Hiromi Kohmoto,1 Haruka Nagumo,1 Masato Wakakura,1 Goji Tomita21Inouye Eye Hospital, Chiyoda-ku, Tokyo, 2Second Department of Ophthalmology, Toho University School of Medicine, Meguro-ku ...
Inoue K, Fujimoto T, Higa R, Moriyama R, Kohmoto H, Nagumo H, Wakakura M, Tomita G   +7 more
doaj  

Efficacy and Safety of Topical Timolol in Localized Superficial Hemangiomas: A Prospective Controlled Open-label Study

Indian Journal of Paediatric Dermatology
Background: Infantile hemangiomas (IHs) are common vascular tumors of infancy that often regress spontaneously. However, early treatment may be required to prevent complications. This study evaluated the efficacy and safety of topical timolol maleate 0.5%
Sandipan Dhar, Safia Bashir, Abhijit Saha, Raghubir Banerjee, Rajib Malakar   +4 more
doaj   +1 more source